Please login to the form below

Not currently logged in
Email:
Password:

panobinostat

This page shows the latest panobinostat news and features for those working in and with pharma, biotech and healthcare.

Trial data suggest Abivax’ drug may clear latent HIV

Trial data suggest Abivax’ drug may clear latent HIV

Meanwhile, Novartis and Genentech are collaborating on the ACTIVATE trial that combines the former’s HDAC inhibitor Farydak (panobinostat) with Genentech’s Pegasys (pegylated interferon-alpha2a), which could also generate results

Latest news

More from news
Approximately 4 fully matching, plus 20 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

PM Society Digital Award Finalists
P&P are shortlisted for the ‘Craft in Film’ category at this year’s PM Society Digital Awards...
The Exhibition Hall: Past, Present and Future
As I sit here at another pharma conference, I start to reflect on how they have changed over the years....
Success breeds success
This week we received the exciting news that we have been shortlisted for the Times Business Awards 2019, Tunbridge Wells in the 'Best Business 1-25 Employees' category....

Infographics